Portrait of Susanne Häußler in front of a white background
© HZI/Verena Meier
Susanne Häußler has been a member of the European Academy of Microbiology since March 2026
News

Susanne Häußler elected to European Academy of Microbiology

HZI scientist among 95 new Fellows of prestigious academy

The European Academy of Microbiology (EAM) has announced the election of 95 new Fellows to the network. Among the newly elected members is Prof. Susanne Häußler, head of the department “Molecular Bacteriology” at the Helmholtz Centre for Infection Research (HZI) and at the TWINCORE – Centre for Experimental and Clinical Infection Research, a joint institution of the HZI and Hannover Medical School. Häußler studies multidrug-resistant pathogens and chronic, persistent biofilm-associated infections.

Founded in 2009, the European Academy of Microbiology aims to promote microbiological research in Europe and to strengthen the exchange of ideas between scientists. New Fellows of the EAM are selected by existing members of the Academy through a rigorous nomination and evaluation process. The prestigious recognition highlights Häußler’s outstanding contributions to the fields of microbial genomics and molecular diagnostics. Her department focuses on identifying the genetic determinants that enable Pseudomonas aeruginosa to adapt to a persistent, chronic infection state and develop resistance to antimicrobials. This research is driving the development of innovative diagnostic tools for accurately profiling resistance and paving the way for new therapeutic strategies to combat therapy-resistant biofilm infections. “Being elected to the EAM is a great honor. I look forward to contributing to the Academy’s mission of promoting microbiology across Europe,” says Häußler.

About the European Academy of Microbiology (EAM)

The European Academy of Microbiology is part of the Federation of European Microbiological Societies (FEMS) network and brings together eminent microbiologists whose work has significantly advanced the field. Through the collective expertise of its Fellows, the Academy contributes to scientific dialogue, supports emerging priorities in microbiology, and helps amplify the impact of microbiological research for society.

Further information
[Translate to English:] Charlotte Schwenner

Press contact

Dr Charlotte Schwenner
Science Editor
+49 531 6181-1406

Research Groups

Locations

Related News

Pseudocolored cells of Pseudomonas aeruginosa
News

When bacteria remember

An international research team led by the Helmholtz Centre for Infection Research (HZI) has discovered a new strategy used by the human pathogen Pseudomonas aeruginosa to adapt to its host. In the journal Proceedings of the National Academy of Sciences (PNAS), the researchers demonstrate that epigenetic processes can lead to the emergence of distinct sub-populations within genetically identical bacterial populations. This heterogeneity may be a key for bacteria to establish successful infections.
[Translate to English:] 3D-kontrastierte Oberflächenstruktur von LasB (beige) mit einem Inhibitor der 3. Generation (dunkelblau), der Zink (grau) bindet.
News

Research team develops active substance against germ that destroys the cornea of the eye

Infectious keratitis blinds 1.5 million people worldwide every year. This severe eye disease is often caused by the hospital germ Pseudomonas aeruginosa, which the World Health Organization considers one of the most dangerous bacteria of its kind. Now, scientists at Saarland University and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have found a way to combat this resilient pathogen. Their study has been published in Advanced Science. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.
Electron micrograph of Pseudomonas aeruginosa
News

New starting point discovered in the fight against Pseudomonas aeruginosa

Pseudomonas aeruginosa is an important opportunistic pathogen responsible for life-threatening infections that are associated with high rates of morbidity and mortality. Researchers from TWINCORE, the Centre for Experimental and Clinical Infection Research in Hannover, and the Helmholtz Centre for Infection Research (HZI) in Braunschweig have now been able to show that an enzyme controls virulence through modification of tRNAs.